One Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $321K | Buy |
+5,291
| New | +$308K | 0.01% | 443 |
|
|
2023
Q2 | – | Sell |
-8,708
| Closed | -$604K | – | 278 |
|
|
2023
Q1 | $604K | Sell |
8,708
-182
| -2% | -$12.8K | 0.03% | 204 |
|
|
2022
Q4 | $640K | Sell |
8,890
-3,059
| -26% | -$231K | 0.03% | 194 |
|
|
2022
Q3 | $849K | Sell |
11,949
-410
| -3% | -$29.7K | 0.05% | 176 |
|
|
2022
Q2 | $951K | Sell |
12,359
-1,963
| -14% | -$150K | 0.06% | 171 |
|
|
2022
Q1 | $1.04M | Sell |
14,322
-658
| -4% | -$44.2K | 0.06% | 172 |
|
|
2021
Q4 | $934K | Buy |
14,980
+514
| +4% | +$30.2K | 0.07% | 143 |
|
|
2021
Q3 | $855K | Buy |
14,466
+518
| +4% | +$34.1K | 0.07% | 133 |
|
|
2021
Q2 | $932K | Buy |
13,948
+1
| +0% | +$65 | 0.08% | 126 |
|
|
2021
Q1 | $880K | Buy |
13,947
+148
| +1% | +$9.21K | 0.1% | 111 |
|
|
2020
Q4 | $856K | Buy |
13,799
+1,487
| +12% | +$91.4K | 0.1% | 111 |
|
|
2020
Q3 | $742K | Sell |
12,312
-142
| -1% | -$8.55K | 0.1% | 106 |
|
|
2020
Q2 | $732K | Buy |
12,454
+31
| +0.2% | +$1.85K | 0.11% | 115 |
|
|
2020
Q1 | $692K | Sell |
12,423
-330
| -3% | -$20.2K | 0.12% | 115 |
|
|
2019
Q4 | $819K | Sell |
12,753
-1,727
| -12% | -$98.9K | 0.13% | 104 |
|
|
2019
Q3 | $734K | Sell |
14,480
-780
| -5% | -$36.7K | 0.12% | 108 |
|
|
2019
Q2 | $692K | Buy |
15,260
+820
| +6% | +$38.2K | 0.12% | 111 |
|
|
2019
Q1 | $689K | Sell |
14,440
-2,465
| -15% | -$123K | 0.12% | 109 |
|
|
2018
Q4 | $879K | Sell |
16,905
-375
| -2% | -$20.1K | 0.18% | 103 |
|
|
2018
Q3 | $1.07M | Sell |
17,280
-4,947
| -22% | -$294K | 0.19% | 97 |
|
|
2018
Q2 | $1.23M | Sell |
22,227
-15,862
| -42% | -$857K | 0.23% | 90 |
|
|
2018
Q1 | $2.41M | Buy |
38,089
+375
| +1% | +$24.1K | 0.47% | 65 |
|
|
2017
Q4 | $2.31M | Sell |
37,714
-900
| -2% | -$56.3K | 0.46% | 71 |
|
|
2017
Q3 | $2.46M | Buy |
38,614
+100
| +0.3% | +$5.84K | 0.51% | 64 |
|
|
2017
Q2 | $2.15M | Buy |
38,514
+15,453
| +67% | +$841K | 0.63% | 59 |
|
|
2017
Q1 | $1.25M | Buy |
23,061
+18,550
| +411% | +$1.02M | 0.39% | 74 |
|
|
2016
Q4 | $264K | Hold |
4,511
| – | – | 0.08% | 104 |
|
|
2016
Q3 | $243K | Hold |
4,511
| – | – | 0.08% | 108 |
|
|
2016
Q2 | $332K | Hold |
4,511
| – | – | 0.12% | 99 |
|
|
2016
Q1 | $288 | Hold |
4,511
| – | – | 0.01% | 103 |
|
|
2015
Q4 | $310K | Sell |
4,511
-76
| -2% | -$5.02K | 0.11% | 109 |
|
|
2015
Q3 | $272K | Sell |
4,587
-100
| -2% | -$6.34K | 0.1% | 109 |
|
|
2015
Q2 | $312K | Sell |
4,687
-2,975
| -39% | -$196K | 0.09% | 121 |
|
|
2015
Q1 | $494K | Buy |
7,662
+125
| +2% | +$7.83K | 0.15% | 104 |
|
|
2014
Q4 | $445K | Hold |
7,537
| – | – | 0.17% | 101 |
|
|
2014
Q3 | $386K | Hold |
7,537
| – | – | 0.14% | 104 |
|
|
2014
Q2 | $366K | Hold |
7,537
| – | – | 0.15% | 103 |
|
|
2014
Q1 | $392K | Buy |
+7,537
| New | +$401K | 0.15% | 107 |
|
Other funds holding BMY
VCM
VPM
One Capital Management's BMY Position: Q1 2026 in Review
One Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,291 shares worth $321K. The stake represents 0.01% of the portfolio and ranks #443 among its holdings. This is a return to the name: One Capital Management previously reported a position in BMY as recently as Q1 2023.
One Capital Management first reported a position in BMY in Q1 2014 and has held it in 38 quarters since. The position peaked at $2.46M in Q3 2017. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- One Capital Management held 5,291 shares of Bristol-Myers Squibb worth $321K as of Q1 2026.
- Bristol-Myers Squibb was a new One Capital Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of One Capital Management's portfolio in Q1 2026, its #443 holding.
- One Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 38 quarters since.
- One Capital Management's Bristol-Myers Squibb position peaked at $2.46M in Q3 2017.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.